BRCAplus Themenreise 3/2025 – Rezidivtherapie

We had fascinating presentations as part of our third BRCA-themed trip. Experts from LMU Munich and Charité Berlin spoke about recurrence therapy and current treatment options. This information is valuable not only for patients but also for family members who want to learn about the role of risk genes in ovarian cancer and other gynecological tumors. The program in detail: "Indications & Significance of Recurrence Surgery" Dr. Christina Tauber — Resident Physician at the Department of Gynecology & Obstetrics, LMU University Hospital Munich "Treatment Options for Recurrent Ovarian Cancer" Dr. Anca Chelariu-Raicu — Consultant Physician at the Department of Gynecology & Obstetrics, LMU University Hospital Munich "What to Do When Chemotherapy Is No Longer Effective Due to Platinum Resistance?" Prof. Dr. med. Jalid Sehouli — Director of the Department of Gynecology with Center for Oncological Surgery at Charité Campus Virchow-Klinikum Moderator: Susanne Fechner Head of the German Ovarian Cancer Foundation _________________________________________ Links to the event: www.brca-infotour.de stiftung-eierstockkrebs.de forum-gyn-onkologie.de studienportal-gyn.de Instagram: @stiftung_eierstockkrebs @forum_gyn_onkologie